# Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle

> **NCT02547441** · PHASE3 · COMPLETED · sponsor: **Maruho Co., Ltd.** · enrollment: 463 (actual)

## Conditions studied

- Rosacea

## Interventions

- **DRUG:** CLS001 (Omiganan)
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT02547441
- **Lead sponsor:** Maruho Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2017-07-05
- **Final completion:** 2018-04-13
- **Target enrollment:** 463 (ACTUAL)
- **Last updated:** 2022-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02547441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02547441, "Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02547441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*